Synthetic glucocorticoids in the environment: first results on their potential impacts on fish.

Human pharmaceuticals have been shown to be entering the aquatic environment in quantities that may produce adverse effects to aquatic organisms. This paper investigates the impacts of synthetic glucocorticoids (GCs), which are used in large amounts as anti-inflammatory drugs, on fish. Mammalian cell lines were transiently transfected with trout corticosteroid receptors (GR1, GR2, and MR) and the transactivation abilities of ten of the most prescribed GCs in the UK were measured in vitro. They showed significantly higher activity with GR2 than with GR1. In order to assess any impacts in vivo, adult fathead minnows were exposed to either 1 μg prednisolone/L or 1 μg beclomethasone dipropionate/L for 21 days. Plasma glucose concentrations were increased and leucocytes were reduced significantly in GC-exposed groups compared to the control group. In another experiment, fish were exposed to three different concentrations of Beclomethasone dipropionate and a dose-dependent increase of plasma glucose was found. The results suggest that low concentrations of synthetic GCs present in water could cause adverse effects on fish. Therefore, quantification of GCs in the aquatic environment and the effects of GCs at environmentally relevant concentrations are required in order to determine if GCs pose a threat to wild fish populations.

[1]  C. Tyler,et al.  Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fish , 2010, Critical reviews in toxicology.

[2]  V. Laudet,et al.  Evidence for two distinct functional glucocorticoid receptors in teleost fish. , 2003, Journal of molecular endocrinology.

[3]  John P. Sumpter,et al.  Pharmaceuticals in the Aquatic Environment: Steroids and Anti-Steroids as High Priorities for Research , 2010 .

[4]  K Kümmerer,et al.  Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review. , 2001, Chemosphere.

[5]  R. Wakeman,et al.  Consumption and Environmental Hazards of Pharmaceutical Substances in the UK , 2003 .

[6]  C. A. Harris,et al.  Evidence of estrogenic mixture effects on the reproductive performance of fish. , 2007, Environmental science & technology.

[7]  Annemarie P van Wezel,et al.  High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands. , 2010, Environmental science & technology.

[8]  Aleem Ahmed Khan,et al.  Diclofenac residues as the cause of vulture population decline in Pakistan , 2004, Nature.

[9]  Oliver A.H. Jones,et al.  Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. , 2002, Water research.

[10]  Anna K. Greenwood,et al.  Multiple corticosteroid receptors in a teleost fish: distinct sequences, expression patterns, and transcriptional activities. , 2003, Endocrinology.

[11]  D. Larsson,et al.  Effluent from drug manufactures contains extremely high levels of pharmaceuticals. , 2007, Journal of hazardous materials.

[12]  G. Flouriot,et al.  11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor. , 2005, Endocrinology.

[13]  J. Sumpter,et al.  Rapid bioconcentration of steroids in the plasma of three‐spined stickleback Gasterosteus aculeatus exposed to waterborne testosterone and 17β‐oestradiol , 2007 .

[14]  J. Sumpter,et al.  On the use of dexamethasone to block the pituitary-interrenal axis in the brown trout, Salmo trutta L. , 1987, General and comparative endocrinology.

[15]  A. D. Pickering,et al.  Stress responses and disease resistance in salmonid fish: Effects of chronic elevation of plasma cortisol , 1989, Fish Physiology and Biochemistry.

[16]  Jianying Hu,et al.  Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. , 2007, Environmental science & technology.

[17]  T. Heberer.  Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.

[18]  J N Lester,et al.  Human pharmaceuticals in the aquatic environment a review. , 2001, Environmental technology.

[19]  T. W. Moon,et al.  Cortisol in teleosts: dynamics, mechanisms of action, and metabolic regulation , 1999, Reviews in Fish Biology and Fisheries.

[20]  T. Ternes.  Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[21]  M. Lürling,et al.  Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. , 2006, Aquatic toxicology.

[22]  T. Pottinger,et al.  Evaluation of flow cytometry as a method for quantification of circulating blood cell populations in salmonid fish , 1993 .

[23]  Vijayan,et al.  Metabolic effects of cortisol treatment in a marine teleost, the sea raven , 1996, The Journal of experimental biology.

[24]  J. Sumpter,et al.  The deleterious effects of cortisol implantation on reproductive function in two species of trout, Salmo trutta L. and Salmo gairdneri Richardson. , 1989, General and comparative endocrinology.

[25]  T. Runnalls,et al.  Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic progestin, Norethindrone. , 2010, Aquatic toxicology.